1mg, best e pharmacy in India

CAMPATH 30MG INJECTION

Injection
MRP: Rs. 86.25 for 1 vial(s) (1 injection each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition for CAMPATH

Alemtuzumab(30 mg)

food interaction for CAMPATH

alcohol interaction for CAMPATH

pregnancy interaction for CAMPATH

lactation interaction for CAMPATH

food
alcohol
pregnancy
lactation
It can be taken with or without food, but it is better to take Campath 30mg injection at a fixed time.
Interaction with alcohol is unknown. Please consult your doctor.
Campath 30mg injection may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
WEIGH RISKS VS. BENEFITS
Unknown. Human and animal studies are not available. Please consult your doctor.

SALT INFORMATION for CAMPATH

Alemtuzumab(30 mg)

Uses

Campath 30mg injection is used in the treatment of blood cancer (chronic lymphocytic leukemia) and multiple sclerosis (ms).

How it works

Campath 30mg injection is a monoclonal antibody and works on the immune system to destroy cancer cells.  In treatment of multiple sclerosis, Campath 30mg injection works by improving the immune system.

Common side effects

Vomiting, Nausea, Anxiety, Bloody diarrhea, Headache, Insomnia, Loss of appetite, Mouth ulcer, Muscle pain, Stomach pain, Uncoordinated body movements

SUBSTITUTES for CAMPATH

No substitutes found

Expert advice for CAMPATH

  • Alemtuzumab may sometimes cause life-threatening reactions like chest pain, breathlessness, slow or irregular heartbeat and therefore you will be closely monitored during and 2 hours after the infusion.
  • Seek immediate medication attention if you notice unusual bruising or bleeding, blood in urine, swelling of legs or feet, or if you cough up blood. 
  • Avoid activities that may increase your risk of bleeding or injury. Take necessary care to prevent bleeding while shaving or brushing your teeth. 
  • Serious infections may occur during alemtuzumab treatment. Inform doctor immediately if you develop fever, chills, cough, mouth sores, or trouble breathing.
  • Avoid contact with people who have infections.
  • Do not receive live vaccines if you have recently received alemtuzumab.
 

Frequently asked questions for CAMPATH

Alemtuzumab

Q.Is alemtuzumab FDA approved for multiple sclerosis?
Yes, Alemtuzumab is FDA approved for Multiple sclerosis

Q.How is alemtuzumab administered?
Alemtuzumab is administered as an IV infusion over 2 hours (3mg/day) until infusion reactions are ≤grade 2, then 10mg/day on the alternate day and 30mg/day on the next alternate day. 30mg/day dose is continued every alternate day, for 12 weeks.

Articles


Content on this page was last updated on 30 October, 2014, by Dr. Varun Gupta (MD Pharmacology)